https://tissuepathology.com Educational and informative Fri, 08 May 2026 12:42:25 +0000 en-US hourly 1 https://tissuepathology.com/wp-content/uploads/2017/07/cropped-Portrait_640x960px-32x32.png https://tissuepathology.com 32 32 https://tissuepathology.com/2026/05/08/proscia-wins-2026-medtech-breakthrough-award-for-turning-the-moment-of-diagnosis-into-drug-development-insights/ Fri, 08 May 2026 12:42:25 +0000 https://tissuepathology.com/?p=24405 Proscia Honored alongside IQVIA, Medidata, and Thermo Fisher Scientific PHILADELPHIA — May 7, 2026 — Proscia®, a company bringing pathology to the center of precision medicine, has been named a winner in the 10th annual MedTech Breakthrough Awards, marking its second consecutive year of recognition. It was honored for enabling pharmaceutical companies to advance precision therapies […]

The post Proscia Wins 2026 MedTech Breakthrough Award for Turning the Moment of Diagnosis into Drug Development Insights first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/05/07/roche-enters-into-a-definitive-merger-agreement-to-acquire-pathai-to-transform-ai-driven-diagnostics/ Thu, 07 May 2026 13:26:42 +0000 https://tissuepathology.com/?p=24403 PathAI’s best-in-class Image Management System (IMS) with advanced AI analysis and workflow capabilities will complement Roche’s digital pathology portfolio to drive laboratory efficiency Combining Roche’s strong position in companion diagnostics and PathAI’s advanced AI platform helps accelerate clinical therapy development, foster the discovery of new biomarkers, and create novel diagnostic tools These integrated capabilities will […]

The post Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/05/06/caris-life-sciences-launches-caris-mi-clarity-the-first-and-only-ai-powered-test-to-predict-both-early-and-late-distant-recurrence-risk-in-breast-cancer-at-the-time-of-diagnosis/ Wed, 06 May 2026 12:03:35 +0000 https://tissuepathology.com/?p=24400 Caris MI Clarity leverages AI to transform how recurrence risk is understood and applied in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer IRVING, Texas, May 5, 2026 /PRNewswire/ — Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today announced the launch of Caris MI Clarity™, the first prognostic test designed […]

The post Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/04/29/evident-announces-6th-annual-image-of-the-year-award-winners/ Wed, 29 Apr 2026 13:25:16 +0000 https://tissuepathology.com/?p=24385 EVIDENT: Star-like neurospheres brilliantly connect our inner and outer worlds NEEDHAM, Mass., April 28, 2026 (GLOBE NEWSWIRE) — Evident unveiled the winners of its sixth annual Image of the Year contest, an awards competition that recognizes the world’s best in scientific microscopic imaging. The winners were selected from submissions from 34 countries around the world. Global […]

The post EVIDENT Announces 6th Annual Image of the Year Award Winners first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/04/28/histoindex-extends-access-to-its-mash-diagnostic-offering-through-new-partnerships-in-texas-and-california/ Tue, 28 Apr 2026 11:50:17 +0000 https://tissuepathology.com/?p=24383 SINGAPORE, April 28, 2026 /PRNewswire/ — HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced the continued expansion of its commercial partnership network in the United States with the addition of two new hepatology and gastroenterology centers – Houston Research Institute (HRI) Kingwood and Knowledge Research Center (KRC) in Orange, California. HistoIndex […]

The post HistoIndex Extends Access To Its MASH Diagnostic Offering Through New Partnerships In Texas And California first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/04/27/fimlab-expands-utilization-of-aiforias-clinical-ai-solutions/ Mon, 27 Apr 2026 12:10:53 +0000 https://tissuepathology.com/?p=24380 Fimlab Laboratories expands the use of Aiforia’s AI solutions for breast cancer diagnostics, bringing multi-organ Ki67 biomarker quantification into routine clinical use. Aiforia Technologies Plc, Press Release, April 27, 2026 at 9:00 a.m. EEST Aiforia Technologies Plc announced today that Fimlab Laboratories in Finland has expanded the use of Aiforia’s AI solutions in routine clinical […]

The post Fimlab expands utilization of Aiforia’s clinical AI solutions first appeared on Tissuepathology.com.]]>